Marie Dusaud
Research Subjects
Marie Dusaud has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Xavier Durand
Department of Urology, Hopital d'Instruction des Armees Begin, Saint Mandé, France
2 shared publicationsYounes Bayoud
Department of Urology, Hopital d'Instruction des Armees Begin, Saint Mandé, France
2 shared publicationsA. Descazeaud
1 shared publicationA. Houlgatte
1 shared publicationAlain Houlgatte
Hôpital d'Instruction des Armées du Val-de-Grâce, Paris, France
1 shared publicationArnaud Méjean
Hôpital Européen Georges Pompidou, Paris, France
1 shared publication
Latest Publications
- Open Access
Chronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives
Radiation cystitis is a potential complication following the therapeutic irradiation of pelvic cancers. Its clinical management remains unclear, and few preclinical data are available on its underlying pathophysiology. The therapeutic strategy is difficult to establish because few prospective and randomized trials are available. In this review, we report on the clinical presentation and pathophysiology of radiation cystitis. Then we discuss potential therapeutic approaches, with a focus on the immunopathological processes underlying the onset of radiation cystitis, including the fibrotic process. Potential therapeutic avenues for therapeutic modulation will be highlighted, with a focus on the interaction between mesenchymal stromal cells and macrophages for the prevention and treatment of radiation cystitis.
Open AccessChronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives
Radiation cystitis is a potential complication following the therapeutic irradiation of pelvic cancers. Its clinical management remains unclear, and few preclinical data are available on its underlying pathophysiology. The therapeutic strategy is difficult to establish because few prospective and randomized trials are available. In this review, we report on the clinical presentation and pathophysiology of radiation cystitis. Then we discuss potential therapeutic approaches, with a focus on the immunopathological processes underlying the onset of radiation cystitis, including the fibrotic process. Potential therapeutic avenues for therapeutic modulation will be highlighted, with a focus on the interaction between mesenchymal stromal cells and macrophages for the prevention and treatment of radiation cystitis.
- 18 November 2016
- Published by Wiley in Journal of Surgical Oncology
- Vol. 114 (8) , 992-996
Post‐chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study
Background and Objectives: To identify predictive preoperative factors of the presence of teratoma in retroperitoneal lymph node dissection specimens.Methods: We performed a 20 years multicenter retrospective analysis of all patients who underwent retroperitoneal lymph node dissection for residual masses after chemotherapy (PC‐RPLND). Patients had undergone PC‐RPLND after chemotherapy for advanced testicular cancer. The histologic components of the primary tumor were compared with those of the residual masses using logistic regression.Results: A total of 469 NSGCT patients underwent PC‐RPLND (complete data available for 211). By PC‐RPLND, necrosis was found in 84 cases, teratoma in 102 cases, and viable tumor in 25 cases. The univariate and multivariate analyses showed that teratoma (P = 0.001 and P = 0.002, respectively) and yolk sac tumor (P = 0.009 and P = 0.035, respectively) in orchiectomy specimens were statistically significant predictors of the presence of teratoma in retroperitoneal lymph nodes.Conclusions: PC‐RPLND is the standard treatment for any supracentimetric residual lesion. This procedure is associated with a high morbidity, and almost half patients are overtreated. The presence of teratoma and yolk sac tumor in the orchiectomy specimen were independent significant predictors of teratoma in retroperitoneal masses. J. Surg. Oncol. 2016;114:992–996.
- 18 November 2016
- Published by Wiley in Journal of Surgical Oncology
- Vol. 114 (8) , 992-996
Post‐chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study
Background and Objectives: To identify predictive preoperative factors of the presence of teratoma in retroperitoneal lymph node dissection specimens.Methods: We performed a 20 years multicenter retrospective analysis of all patients who underwent retroperitoneal lymph node dissection for residual masses after chemotherapy (PC‐RPLND). Patients had undergone PC‐RPLND after chemotherapy for advanced testicular cancer. The histologic components of the primary tumor were compared with those of the residual masses using logistic regression.Results: A total of 469 NSGCT patients underwent PC‐RPLND (complete data available for 211). By PC‐RPLND, necrosis was found in 84 cases, teratoma in 102 cases, and viable tumor in 25 cases. The univariate and multivariate analyses showed that teratoma (P = 0.001 and P = 0.002, respectively) and yolk sac tumor (P = 0.009 and P = 0.035, respectively) in orchiectomy specimens were statistically significant predictors of the presence of teratoma in retroperitoneal lymph nodes.Conclusions: PC‐RPLND is the standard treatment for any supracentimetric residual lesion. This procedure is associated with a high morbidity, and almost half patients are overtreated. The presence of teratoma and yolk sac tumor in the orchiectomy specimen were independent significant predictors of teratoma in retroperitoneal masses. J. Surg. Oncol. 2016;114:992–996.
- Open Access
- 27 April 2015
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2015, 1-3
Unusual Presentation of Testicular Cancer with Tumor Thrombus Extending to the Inferior Vena Cava
A 45-year-old man with a left testis tumor with a 25 mm para-aortic lymph node swelling, multiple bilateral pulmonary metastases, bilateral pulmonary embolism, and inferior vena cava (IVC) thrombus underwent a radical orchidectomy in our institution. The thrombus extended from the left gonadal vein to the left renal vein to the IVC. The fluorine-18 fluorodeoxyglucose (f-FDG) positron emission tomography (PET) computerized tomography (CT) demonstrated a hypermetabolic focus in the retroperitoneum and in the IVC thrombus. Before orchidectomy only lactate dehydrogenase (LDH) was high but all the serum tumor markers increased postoperatively. The tumor was staged pT1N2M1aS1, which was an intermediate prognosis, based on the International Germ Cell Cancer Collaborative Group consensus (IGCCCG). After 4 courses of bleomycin, etoposide, and cisplatin (BEP) chemotherapy the patient’s tumor markers normalized and the thrombus disappeared. There was only one residual retroperitoneal lymph node M1. Retroperitoneal lymph node dissection was performed. The pathological examination revealed only necrotic tissues. The patient has been disease-free since surgery.
- 27 April 2015
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2015, 1-3
Open AccessUnusual Presentation of Testicular Cancer with Tumor Thrombus Extending to the Inferior Vena Cava
A 45-year-old man with a left testis tumor with a 25 mm para-aortic lymph node swelling, multiple bilateral pulmonary metastases, bilateral pulmonary embolism, and inferior vena cava (IVC) thrombus underwent a radical orchidectomy in our institution. The thrombus extended from the left gonadal vein to the left renal vein to the IVC. The fluorine-18 fluorodeoxyglucose (f-FDG) positron emission tomography (PET) computerized tomography (CT) demonstrated a hypermetabolic focus in the retroperitoneum and in the IVC thrombus. Before orchidectomy only lactate dehydrogenase (LDH) was high but all the serum tumor markers increased postoperatively. The tumor was staged pT1N2M1aS1, which was an intermediate prognosis, based on the International Germ Cell Cancer Collaborative Group consensus (IGCCCG). After 4 courses of bleomycin, etoposide, and cisplatin (BEP) chemotherapy the patient’s tumor markers normalized and the thrombus disappeared. There was only one residual retroperitoneal lymph node M1. Retroperitoneal lymph node dissection was performed. The pathological examination revealed only necrotic tissues. The patient has been disease-free since surgery.
- 1 September 2012
- Published by Elsevier in Progrès en Urologie
- Vol. 22 (10) , 568-571
Le growing teratoma syndrome
- 1 September 2012
- Published by Elsevier in Progrès en Urologie
- Vol. 22 (10) , 568-571
Le growing teratoma syndrome
- 29 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e610-e610b
610 Oncological outcomes of positive surgical margin locations in pn0 m0 bladder cancer
- 29 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e610-e610b
610 Oncological outcomes of positive surgical margin locations in pn0 m0 bladder cancer